What Does $3.2 Billion Buy? Pharmaceutical-Biotech Industry Wraps Up Construction on 71 North American Projects

SUGAR LAND--March 27, 2012--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Theories abound regarding the Pharmaceutical-Biotech Industry, and the only fact that has emerged is it has changed and continues to do so. No construction, abundant construction, consolidation, expansion; oddly enough, all apply to this industry in transition. Sometimes, it helps to only deal with concrete facts, as in the construction concrete poured to build the 71 projects that wrapped up construction during the first quarter in North America.

Other companies featured: Cubist Pharmaceuticals (NASDAQ:CBST), Grifols USA (NASDAQ:GRFS)

Read the Complete Article >>>

Details on this Article:
Industry Segment: Pharmaceutical & Biotech
Word Count: 518 Words
Attachment: IIR Chart - Pharma-Biotech Project Completed in 1Q12

Listen to Today's News

News Audio Library

Sync News Podcasts

Username:        Password:    

Related Articles

  Just Less than 400 U.S. Plants to Begin Operations in Second Half of 2013, ...

  U.S. Jobs Numbers Edge Up as Industrial Construction Starts Remain Strong i...

  INTERPHEX 2013: It's a Wrap on Pharma's Biggest Conference of the Year

  Got BIO? Better Get It! BIO 2013 Report Credits Industry with 1.6 Million H...

  BIO 2013 International Industry Conference Launches its 20th Year in the Wi...